16 The agencies pointed out 17 that commenters also noted that enabling States to more easily and, perhaps, therefore, more frequently, update their EHB-benchmark plans could result in expanded coverage for, among other things, maternity care, substance use disorder care, obesity care, and chronic disease management. So while most current EHB benchmark plans do not include coverage for anti-obesity medications, that could certainly change in the coming years
contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
It helps to avoid a form of anemia called megaloblastic anemia, which results in symptoms like chronic exhaustion and weakness
The market for liraglutide has seen substantial growth in recent years
Utah residents recognize the importance of taking immediate action